Stock Details
BAX is Baxter International Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 58.84$. Average daily volumn in 3 months 3.04M. Market cap 27.12B



Stock symbol : BAX. Exchange : NYSE. Currency : USD
Lastest price : 53.86$. Total volume : 3.82M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Baxter International Inc. (BAX)
Last Price
53.86$
Change
-1.44
Volume
3.82M

Previous Close55.30
Open55.50
Day Range53.85-55.71
Bid53.71 x 800
Ask54.08 x 800
Volume3.82M
Average Volume3.04M
Market Cap27.12B
Beta0.60
52 Week Range53.78-89.70
Trailing P/E26.93
Foward P/E13.99
Dividend (Yield %)2.15%
Ex-Dividend Date2022-09-01



Financial Details


According to Baxter International Inc.'s financial reports the company's revenue in 2021 were 12.78B an increase( +9.09%) over the years 2020 revenue that were of 11.67B. In 2021 the company's total earnings were 1.28B while total earnings in 2020 were 1.1B(0%).


Loading ...



Organization

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological... products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Market Cap:
27.12B
Revenue:
12.78B
Total Assets:
33.52B
Total Cash:
2.95B


News about "Baxter International Inc."

With 88% institutional ownership, Baxter International Inc. (NYSE:BAX) is a favorite amongst the big guns

Source from : Yahoo - 11 days ago

A look at the shareholders of Baxter International Inc. (NYSE:BAX) can tell us which group is most powerful. The group holding the most number of shares in the company, around 88% to be precise ...See details»


baxter international inc.

Source from : Fox Business - 2 days ago

Baxter International Inc. BAX 0.27% is in advanced talks to buy medical-equipment maker Hill-Rom Holdings Inc. HRC 0.96% for around $10 billion, according to people familiar with the matter.See details»


Baxter International Inc. (NYSE:BAX) Short Interest Up 12.6% in August

Source from : Defense World - 11 days ago

Baxter International Inc. (NYSE:BAX โ€“ Get Rating) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 5,090,000 ...See details»


advisornet-financial-inc-sells-419-shares-of-baxter-international-inc-nysebax-image

AdvisorNet Financial Inc Sells 419 Shares of Baxter International Inc. (NYSE:BAX)

Source from : Defense World - 10 days ago

AdvisorNet Financial Inc lowered its position in shares of Baxter International Inc. (NYSE:BAX โ€“ Get Rating) by 16.7% in the 2nd quarter, according to its most recent Form 13F filing with the ...See details»


Baxter International to Split In Response to Macro Challenges

Source from : TheStreet.com - 21 days ago

Baxter International's split was also characterized as a response to diverging dynamics between the two businesses and a rapidly changing macro-environment. Baxter International's split was also ...See details»


Is Baxter Going to Shed Two of its Kidney Care Businesses?

Source from : MD&M East - 4 days ago

Baxter could be on the way to shedding two units within its kidney care business, according to a report from Bloomberg, citing people familiar with the matter. The Deerfield, IL-based company could be ...See details»


Baxter is said to evaluate sale of two of its kidney businesses

Source from : Seeking Alpha - 18 days ago

To ensure this doesnโ€™t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...See details»


Elouise Chin, Baxter International Inc.

Source from : hcamag.com - 2 years ago

Today, this driven, passionate, and high-driven lady is pursuing talent management in SEA with Baxter, bringing with her the competencies she gained from working at OCBC Bank and PwC.See details»


Should You Buy Baxter Stock Under $60?

Source from : Forbes - 17 days ago

Baxter stock (NYSE: BAX) has seen a 32% fall this year, underperforming the broader S&P500 index, down 17%. Even if we look at the longer term, BAX stock, with -10% returns from levels seen in ...See details»


Motion Sickness Drugs Market, Availability of over-the-counter (OTC) drugs to boost market growth - Technavio

Source from : Benzinga.com - 1 days ago

Technavio's latest offering, the Motion Sickness Drugs Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The ...See details»


Needle Free IV Connectors Market Future Trends Outlook 2022, and Forecast to 2029 โ€“ Baxter International, Inc., B. Braun Melsungen AG

Source from : MarketWatch - 10 days ago

The Global Needle Free IV Connectors Market Size was estimated at USD 710.28 million in 2021 and is projected to reach USD 1314.43 million by 2028, exhibiting a CAGR of 9.19% during the forecast ...See details»


Baxter product recall โ€ข Hospitals' financial crises in pandemic aftermath โ€ข Illinois nears 200,000 booster shots

Source from : Crain's Chicago Business - 13 days ago

BAXTER FACES NEW RECALL: The U.S. Food & Drug Administration has recalled another Baxter International medical device over safety concerns. Separately, the Deerfield-based company also is ...See details»


Medical device, drugmakers assess operations after Hurricane Fiona

Source from : Modern Healthcare - 11 days ago

Hurricane Maria hit medical device company Baxter International especially hard. Its Puerto Rican facilities were largely responsible for making small-volume IV bags, while large-volume bags were ...See details»


Self-Injections Market May Set Epic Growth Story | Abbvie, BD, 3M, Baxter International

Source from : Digital Journal - 1 month ago

Some of the key players involved in the study are Abbvie, Inc., Antares Pharma, Becton Dickinson & Company, 3M Company, Baxter International Inc., Pfizer Inc., Penjet Corporation, PharmaJet ...See details»